Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $914.00 | 36 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $281.67 | 8 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $202.26 | 6 | $0 (2023) |
| ABBVIE INC. | $111.54 | 6 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $100.69 | 6 | $0 (2023) |
| ITI, Inc. | $80.69 | 4 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $45.53 | 2 | $0 (2024) |
| Adlon Therapeutics L.P. | $39.92 | 2 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $33.84 | 1 | $0 (2022) |
| Eisai Inc. | $17.86 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45.53 | 2 | Otsuka America Pharmaceutical, Inc. ($45.53) |
| 2023 | $71.29 | 4 | ABBVIE INC. ($36.45) |
| 2022 | $607.94 | 25 | Janssen Pharmaceuticals, Inc ($182.91) |
| 2021 | $189.24 | 5 | Neurocrine Biosciences, Inc. ($131.46) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: PSYCHIATRY | ||||||
| 03/04/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: PSYCHIATRY | ||||||
| 02/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Central Nervous System | ||||||
| 01/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Neuroscience | ||||||
| 12/01/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Central Nervous System | ||||||
| 11/10/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Central Nervous System | ||||||
| 10/03/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Neuroscience | ||||||
| 09/29/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $34.27 | General |
| Category: Neuropsychiatry | ||||||
| 08/25/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Central Nervous System | ||||||
| 08/04/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Neuroscience | ||||||
| 07/25/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: Neuropsychiatry | ||||||
| 07/18/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Central Nervous System | ||||||
| 07/11/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: PSYCHIATRY | ||||||
| 05/16/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $33.84 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 05/12/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Central Nervous System | ||||||
| 04/27/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: PSYCHIATRY | ||||||
| 04/13/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Neuropsychiatry | ||||||
| 04/07/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: PSYCHIATRY | ||||||
| 03/15/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 2 | 113 | 295 | $22,997 | $10,119 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 62 | 223 | $16,269 | $7,287 | 44.8% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2020 | 24 | 24 | $3,237 | $2,007 | 62.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 27 | 48 | $3,492 | $825.45 | 23.6% |
About Ester Pulliam, PMHNP
Ester Pulliam, PMHNP is a Psychiatric/Mental Health healthcare provider based in Grayson, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2012. The National Provider Identifier (NPI) number assigned to this provider is 1184978785.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ester Pulliam, PMHNP has received a total of $914.00 in payments from pharmaceutical and medical device companies, with $45.53 received in 2024. These payments were reported across 36 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($914.00).
As a Medicare-enrolled provider, Pulliam has provided services to 113 Medicare beneficiaries, totaling 295 services with total Medicare billing of $10,119. Data is available for 1 year (2020–2020), covering 3 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Grayson, GA
- Active Since 11/04/2012
- Last Updated 09/18/2023
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1184978785
Products in Payments
- INGREZZA (Drug) $281.67
- INVEGA SUSTENNA (Drug) $202.26
- VRAYLAR (Drug) $111.54
- AUSTEDO (Drug) $100.69
- CAPLYTA (Drug) $80.69
- ADHANSIA XR (Drug) $39.92
- HETLIOZ (Drug) $33.84
- ABILIFY MAINTENA (Drug) $28.24
- Dayvigo (Drug) $17.86
- REXULTI (Drug) $17.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Grayson
Jalmec Carter- Holifield, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $1,497
Simone Graham-Murray, Np, NP
Psychiatric/Mental Health — Payments: $679.58
Mrs. Joy Enagbare, Np, NP
Psychiatric/Mental Health
Alexis Joseph, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health